Stevens–Johnson syndrome induced by a combination of lamotrigine and valproic acid
Authors:
Open Access
- 1 August 2015
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Pharmacy and Bioallied Sciences
- Vol. 7 (Suppl 2) , S756-S758
Abstract
Lamotrigine and valproic acid are well-tolerated anticonvulsants, but frequently associated with severe cutaneous reactions, such as the Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis, when used in combination. We report a case of SJS likely induced by the use of a lamotrigine and valproic acid regimen and as a dental surgeon it is important to identify such lesion and report to pharmacovigilance.Keywords
This publication has 11 references indexed in Scilit:
- Stevens Johnson syndrome due to nevirapineIndian Journal of Allergy, Asthma and Immunology, 2014
- The current understanding of Stevens–Johnson syndrome and toxic epidermal necrolysisExpert Review of Clinical Immunology, 2011
- Toxic epidermal necrolysis and Stevens-Johnson syndromeOrphanet Journal of Rare Diseases, 2010
- Toxic Epidermal Necrolysis Due to Lamotrigine Monotherapy for Bipolar DisorderTzu Chi Medical Journal, 2009
- Aggrenox (Asasantin retard)‐induced Stevens–Johnson syndromeBritish Journal of Clinical Pharmacology, 2009
- Hypersensitivity to Lamotrigine and Nonaromatic Anticonvulsant Drugs: A ReviewCurrent Pharmaceutical Design, 2008
- Pharmacovigilance: methods, recent developments and future perspectivesEuropean Journal of Clinical Pharmacology, 2008
- Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysisAnnals of Allergy, Asthma & Immunology, 2006
- Toxic Epidermal Necrolysis and Stevens Johnson Syndrome: Our Current UnderstandingAllergology International, 2006
- Suspected lamotrigine-induced toxic epidermal necrolysis.2003